Iconography : Traitement des syndromes secs graves par sérum autologue
暂无分享,去创建一个
C. Baudouin | F. Brignole | P. D'Athis | P. Pisella | C. Creuzot-Garcher | A. Bron | P. Lafontaine | P. D'athis | V. Lapierre | C. Baudouin
[1] K. Tsubota,et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease , 2003, Bone Marrow Transplantation.
[2] C. Creuzot-Garcher,et al. Treatment of Persistent Corneal Epithelial Defects by Autologous Serum , 2002 .
[3] J. M. D. del Castillo,et al. Treatment of Recurrent Corneal Erosions Using Autologous Serum , 2002, Cornea.
[4] E. Tedeschi-Reiner,et al. Amniotic membrane transplantation for ocular surface reconstruction. , 2002, Collegium antropologicum.
[5] K. Tsubota,et al. Treatment of Superior Limbic Keratoconjunctivitis by Application of Autologous Serum , 2001, Cornea.
[6] H. Taylor,et al. Controlled Study of the Use of Autologous Serum in Dry Eye Patients , 2001, Cornea.
[7] J. Daniels,et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies , 2001, The British journal of ophthalmology.
[8] C. Baudouin. The pathology of dry eye. , 2001, Survey of ophthalmology.
[9] K. Tsubota,et al. Multilayered amniotic membrane transplantation for severe ulceration of the cornea and sclera. , 2001, American journal of ophthalmology.
[10] A. Lambiase,et al. NERVE GROWTH FACTOR: AN IMPORTANT MOLECULE FOR TROPHISM AND HEALING OF THE OCULAR SURFACE. , 2000 .
[11] C. Baudouin,et al. Évaluation de la cytotoxicité de trois substituts lacrymaux utilisés dans le traitement des syndromes secs , 2000 .
[12] A. Solomon,et al. The Diagnosis and Management of Dry Eye: A Twenty-five–Year Review , 2000, Cornea.
[13] A. Vigorito,et al. GVHD dry eyes treated with autologous serum tears , 2000, Bone Marrow Transplantation.
[14] K. Tsubota,et al. Treatment of persistent corneal epithelial defect by autologous serum application. , 1999, Ophthalmology.
[15] C. Baudouin,et al. [Dry eye syndromes and the ocular surface]. , 1999, Journal francais d'ophtalmologie.
[16] K. Tsubota,et al. Treatment of dry eye by autologous serum application in Sjögren’s syndrome , 1998, The British journal of ophthalmology.
[17] Vannelli Gb. Dry eye syndrome, tear film, pharmacology of eye drops, and toxicity. , 1997 .
[18] I. Saito,et al. Criteria for diagnosis of Sjögren's syndrome. , 1994, Rheumatic diseases clinics of North America.
[19] S. Tseng,et al. Comparison of fluorescein and rose bengal staining. , 1992, Ophthalmology.
[20] L. Jacobsson,et al. Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. , 1989, Journal of autoimmunity.
[21] P. McDonnell,et al. Immunoglobulin deposition in the cornea after application of autologous serum. , 1988, Archives of ophthalmology.
[22] J. Belmont,et al. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. , 1984, Arthritis and rheumatism.
[23] P. Youinou,et al. Ocular surface lesions due to keratoconjunctivitis sicca: in primary Sjögren's syndrome , 2004, Documenta Ophthalmologica.
[24] K. Tsubota,et al. Clinical application of living-related conjunctival-limbal allograft. , 2002, American journal of ophthalmology.
[25] C. Baudouin,et al. Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A. , 2001, Investigative ophthalmology & visual science.
[26] G. V. van Setten. Dry eye syndrome, tear film, pharmacology of eye drops, and toxicity. , 1997, Current opinion in ophthalmology.